2-Furanacetonitrile, alpha-oxo- - Names and Identifiers
2-Furanacetonitrile, alpha-oxo- - Physico-chemical Properties
Molecular Formula | C6H3NO2
|
Molar Mass | 121.09 |
Density | 1.246 |
Melting Point | 233-236 °C |
Boling Point | 85-87°C 12mm |
Flash Point | 60℃ |
Solubility | DMSO (Slightly), Ethyl Acetate (Slightly) |
Vapor Presure | 1.13mmHg at 25°C |
Appearance | Oil |
Color | Dark Brown |
Sensitive | Moisture Sensitive |
Refractive Index | 1.498 |
2-Furanacetonitrile, alpha-oxo- - Risk and Safety
Hazard Symbols | Xn - Harmful
|
Risk Codes | R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed.
|
Safety Description | S36/37 - Wear suitable protective clothing and gloves.
|
Hazard Class | 6.1 |
2-Furanacetonitrile, alpha-oxo- - Introduction
2-Furylglyoxylontril (2-Furylglyoxylontril) is an organic compound. Its molecular formula is C7H5NO2 and its molecular weight is 135.12g/mol.
Properties: 2-Furylglyoxylonitrile is a colorless liquid with furan ring and formyl nitrile group. It can be dissolved in some organic solvents, such as ethanol, acetone and chloroform. It has a melting point of -25°C and a boiling point of 190°C.
Purpose: 2-Furylglyoxylontril is an important organic synthesis intermediate. It can be used to synthesize a variety of biologically active compounds, such as anticancer drugs, antiviral drugs and pesticides. In addition, it can also be used as a raw material for dyes and coatings.
preparation method: the common preparation method of 2-FurylglyoxylNitrile is obtained by reacting furyl carboxylic acid and dehydrating agent such as pioneer piperidin (pyridinium tosylate). The reaction conditions are generally carried out at room temperature.
Safety Information: 2-Furylglyoxylnitril is irritating to the eyes and skin and may cause allergic reactions. Wear appropriate personal protective equipment such as gloves and glasses when operating. Avoid inhaling its vapors and ensure good ventilation during use. If exposed or inhaled, seek medical help immediately.
Last Update:2024-04-09 20:52:54